×

NewLink Genetics to Host Its Third Quarter 2015 Earnings Conference Call on November 3, 2015

AMES, Iowa, Oct. 23, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of developing novel immuno-oncology and infectious-disease products to improve the lives of patients, reported that it will release its third quarter 2015 financial results on Tuesday, November 3, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results and to give an update on clinical and business development activities.

NewLink’s senior management team will host the conference call, which will be open to all listeners. There will also be a question and answer session following the prepared remarks.

Access to the live call is available by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) five minutes prior to the start of the call. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and using the passcode 66888213. The replay will be available for two weeks from the date of the call.

About NewLink Genetics Corporation
NewLink is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve the lives of patients with cancer. NewLink Genetics' portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. NewLink Genetics' product candidates are designed to harness multiple components of the immune system to combat cancer without significant incremental toxicity, either as a monotherapy or in combination with other treatment regimens. For more information, please visit http://www.newlinkgenetics.com.

Corporate Contact: Jack Henneman Chief Financial Officer 515-598-2561 Investor@Linkp.com Investors: Donna LaVoie or Kristina Coppola LaVoieHealthScience 617-374-8800 X105/7 Media: David Connolly LaVoieHealthScience 617-374-8800 X108 dconnolly@lavoiehealthscience.com

Source:NewLink Genetics Corporation